All posts by admin

28Mar/14

Former Olympic 400m bronze medalist Donna Hartley-Wass has died from heart … – Daily Mail


Daily Mail

Former Olympic 400m bronze medalist Donna Hartley-Wass has died from heart
Daily Mail
‘She had none of the common features of liver failure,’ he added. However he did discover a pigment in her heart which is normally only … ‘I don’t know whether this caused heart failure. I couldn’t see anything which suggests that to be the cause. We

and more »

28Mar/14

Cornwall nurse in plea over organ donation – Western Morning News


Laois Nationalist

Cornwall nurse in plea over organ donation
Western Morning News
The specialist nurse from the Royal Cornwall Hospital will talk to members about organ donation and signing up to the NHS Organ Donor Register, as well as making sure loved ones are informed about the decision. “Organ donation saves lives and families …
‘I feel very lucky’ – Laois transplant recipient shares her experienceLaois Nationalist
READER SUBMITTED: LifeChoice Team Transplant Of CT Fundraiser BreakfastHartford Courant

all 3 news articles »

28Mar/14

Pre-market Gainers: BofI Holding, Inc. (NASDAQ:BOFI), Hansen Medical, Inc … – Gaining Green

Pre-market Gainers: BofI Holding, Inc. (NASDAQ:BOFI), Hansen Medical, Inc
Gaining Green
Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced that the European Commission (EC) has approved Roche’s new subcutaneous (SC) formulation of MabThera® (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell …

and more »

28Mar/14

Roche nabs European approval for time-saving formulation of Rituxan – FiercePharma


Drug Discovery & Development

Roche nabs European approval for time-saving formulation of Rituxan
FiercePharma
Swiss pharma giant Roche ($RHHBY) is pursuing that game plan for some of its hit biotech drugs–and today it scored a victory when European regulators approved a subcutaneous version of its cancer drug Rituxan (rituximab), known as MabThera overseas.
Europe OKs New Formula of Roche Cancer DrugDrug Discovery & Development
Halozyme Platform Wins EC Approval for Roche’s MabThera SCGenetic Engineering News
EC approves Roche’s SC formulation of MabThera for common forms of non News-Medical.net
NASDAQ –Wall Street Journal
all 12 news articles »